-+ 0.00%
-+ 0.00%
-+ 0.00%

CINGULATE REPORTS SAFETY RESULTS FROM FINAL PHASE 3 TRIALS FOR LEAD ADHD ASSET CTX-1301: ON TRACK TO FILE FOR FDA APPROVAL MID-2025

Reuters·03/04/2025 14:00:02

Please log in to view news